Clinical trial Recruiting at 1 site Interventional Ages 18 to 35 Women only

Comparing two methods to predict ovulation outcomes in women with PCOS

Official title: Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS: A Prospective Cohort Study

Run by Cairo University · NCT06793904 · Data updated 2026-11-12

This study is testing two different methods to see which one better predicts ovulation success in women with PCOS who are trying to get pregnant.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexWomen only
Enrollment122 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedJanuary 2026
Study endsJanuary 2026
Registry record updatedFebruary 5, 2025
Trial IDNCT06793904 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18-35 with a diagnosis of PCOS and a history of infertility lasting 1-4 years.

Probably not a fit

Patients with other infertility causes, chronic diseases, or contraindications to pregnancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of two different homeostatic model assessments for insulin resistance (HOMA1-IR and HOMA2-IR) in predicting ovulation outcomes in women diagnosed with Polycystic Ovarian Syndrome (PCOS) who are seeking fertility treatment. A total of 122 participants will undergo insulin resistance assessments and will be treated with the aromatase inhibitor Letrozole to induce ovulation. Ultrasound monitoring will track follicular growth until the dominant follicle reaches the appropriate size for ovulation. The study aims to determine which assessment method provides better predictive outcomes for ovulation.

Why it matters

Potential benefit: If successful, this study could improve ovulation prediction and fertility treatment strategies for women with PCOS.

How similar studies have gone: Previous studies have shown varying success with similar approaches in assessing insulin resistance and fertility outcomes, but this specific comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-35 years
* duration of infertility 1-4 years
* PCOS

Exclusion Criteria:

women with other causes of infertility (tubal factor assessed by laparoscopy or hysterosalpingogram, uterine cavity abnormality assessed by ultrasound or hysteroscopy or male factor assessed by seme analysis),

* endometriosis,
* ovarian cysts,
* endocrinological abnormalities (Diabetes mellitus, hypothalamic, pituitary or thyroid disorders, or hyperprolactinemia),
* women with history of poor ovarian response or ovarian hyperstimulation
* women with chronic diseases, chromosomal, autoimmune or coagulation defects, abnormal leucocytic count or other inflammatory markers
* Women with contraindications to pregnancy.

Where it's running

  • Kasr Alainy medical school
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.